When should antibiotic prophylaxis be administered for dog bite injuries?

Antibiotic Prophylaxis in Dog Bites

Antibiotic prophylaxis for 3-5 days should be given to dog bite patients who are immunocompromised, asplenic, have advanced liver disease, have edema of the affected area, have moderate-to-severe injuries (especially to hand or face), have puncture wounds, or have injuries that may have penetrated bone/tendon/joint capsule 1.

Risk Stratification: Who Needs Prophylaxis

The decision to prescribe prophylactic antibiotics is based on wound severity and host immune competence, not a blanket approach to all dog bites 1.

High-Risk Patients (Give Prophylaxis):

• Immunocompromised patients (any immunosuppressive condition or medications)
• Asplenic patients
• Advanced liver disease
• Preexisting or resultant edema of the affected area
• Moderate to severe injuries, particularly:
  • Hand injuries
  • Facial injuries
  • Foot injuries
  • Genital area bites
• Puncture wounds (especially concerning as they penetrate deeper structures)
• Injuries penetrating periosteum or joint capsule
• Wounds requiring primary closure
• Wounds presenting >9 hours after injury 2

Low-Risk Wounds (Prophylaxis Provides Marginal Benefit):

• Superficial wounds not involving hands, face, or feet
• Non-puncture wounds
• Immunocompetent patients
• Wounds presenting within 12-24 hours that don't meet high-risk criteria 1

Evidence Context

While a meta-analysis showed antibiotics reduce infection risk (relative risk 0.56), with a baseline infection rate of 16% in untreated dog bites 3, the number needed to treat is approximately 14 patients to prevent one infection 3. This supports a selective rather than universal approach. More recent data suggests infection rates may be lower (5.2%) in contemporary practice 4, though puncture wounds carry 4.1 times higher infection risk and closed wounds carry 3.1 times higher risk 4.

Antibiotic Selection

Amoxicillin-clavulanate 875/125 mg twice daily is the first-line agent 1, 5. This provides coverage against both aerobic and anaerobic bacteria, including Pasteurella multocida, the most common pathogen in dog bites.

Alternative Regimens:

• Doxycycline 100 mg twice daily (excellent Pasteurella coverage, but some streptococci resistant)
• Moxifloxacin 400 mg daily (monotherapy with anaerobic coverage)
• Combination therapy: Ciprofloxacin or levofloxacin PLUS metronidazole (if β-lactam allergy)

Avoid:

• Clindamycin alone (misses Pasteurella multocida)
• First-generation cephalosporins (inadequate coverage)

Duration

3-5 days of prophylactic antibiotics is the recommended duration 1. Recent data confirms that limiting antibiotics to ≤3 days does not increase infection rates compared to longer courses 6, supporting adherence to the shorter end of this range for antimicrobial stewardship.

Critical Pitfalls to Avoid

1. Don't prescribe clindamycin monotherapy - it lacks activity against Pasteurella multocida, a key dog bite pathogen 1

2. Don't use first-generation cephalosporins - inadequate spectrum for bite wounds

3. Don't forget tetanus prophylaxis - administer if not vaccinated within 10 years (Tdap preferred over Td if not previously given) 1

4. Don't forget rabies assessment - consult local health officials to determine if rabies postexposure prophylaxis is indicated 1

5. Don't close high-risk wounds primarily without antibiotic coverage - wound closure independently increases infection risk 3-fold 4

Nuances in the Evidence

There is some controversy in the literature. While the IDSA guidelines strongly recommend selective prophylaxis for high-risk wounds 1, recent pediatric studies show no significant difference in infection rates between those receiving and not receiving prophylaxis (5.8% vs 3.0%, p=0.28) 7. However, these studies may be underpowered and don't specifically analyze the high-risk subgroups identified in the guidelines. The safest approach remains following the IDSA guideline criteria, as the consequences of missing a hand, joint, or facial infection can be devastating for function and quality of life.

The Cochrane review suggested limiting prophylaxis to hand injuries and human bites only 1, but this is more restrictive than the IDSA guidelines. Given the low cost and generally favorable safety profile of short-course amoxicillin-clavulanate, and the potentially serious morbidity of infections in high-risk wounds, the broader IDSA criteria are more appropriate for clinical practice.